Frequently
Asked
Questions
Open All FAQs
This study is evaluating an investigational drug to potentially treat interstitial cystitis/bladder pain syndrome (IC/BPS) in women. You may be able to take part in this study if you:
- Are a female between 18 and 75 years old
- Have a confirmed diagnosis of interstitial cystitis/bladder pain syndrome
Approximately 80 female participants will be enrolled.
The first visit (Visit 1) is screening, and the study team will evaluate your eligibility to participate. If you proceed, you will review the study, receive training on the electronic study diary, and complete a series of health assessments.
Qualified participants will have a 50/50 chance of receiving the investigational drug in the first treatment portion of the study. You may get an injection that contains no actual drug (called a placebo) instead of the investigational drug. However, in the second portion of the study, if you choose to receive a second treatment, you will receive the investigational drug. The study can last up to 46 weeks with a total of up to 13 visits.
The investigational drug is a liquid solution administered as an injection into the bladder.
Please discuss your medications with the study center staff and your primary care physician.
Qualified participants will receive all study-related care at no cost.
Clinical research studies are designed in specific ways, and one or more of the answers that you provided were outside of the guidelines for this study. This does not mean you will not qualify for different research studies.
